Before RSV vaccine, virus caused substantial illness in US adults
On Nov. 13, 2024, a study published in JAMA Network Open showed that respiratory syncytial virus (RSV) was…
-
-
Paxlovid cuts COVID hospitalization, death risk and speeds symptom relief, studies find
On Nov. 11, 2024, findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to…
-
Researchers discovered unique genome folding in turtles
On Nov. 11, 2024, a team of researchers led by Iowa State University (ISU) have shown that as…
-
Nasal Swab Tests Predict COVID-19 Disease Severity, Study Finds
On Nov. 6, 2024, researchers from Emory University, in collaboration with scientists at Gladstone Institutes and University of…
-
Study revealed stubborn mistrust in COVID-19 vaccine science
On Nov. 4, 2024, a study conducted by researchers from the CUNY Graduate School of Public Health and…
-
New risks raise pandemic threat on a global scale
On Oct. 14, 2024, the Global Preparedness Monitoring Board (GPMB) released a report that outlined 15 key drivers…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Neurology | NIH | Non-Profit Research | Therapeutics | Vaccine
Study Found Persistent Infection Could Explain Long COVID in Some People
On Oct. 9, 2024, researchers from Brigham and Women’s Hospital found that people with wide-ranging long COVID symptoms…
-
Novavax’s Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Received Authorization in the EU
On Oct. 9, 2024, Novavax announced that the European Commission had granted Marketing Authorization for Novavax’s updated 2024-2025…
-
COVID-19 hospitalization remained higher among older adults
On Oct. 4, 2024, the Centers for Disease Control and Prevention (CDC) published data that showed older adults…
-
GSK invests up to $800 million in Pennsylvania site
On Oct. 24, 2024, GSK announced an $800 million investment that will bring state-of-the-art drug substance manufacturing and…
-
MERS coronavirus case reported in Saudi Arabia
On Oct. 2, 2024, the World Health Organization (WHO) announced it had been notified of one human case…
-
Brain Scans revealed changes from Long COVID Fatigue
On Sept. 27, 2024, a study that evaluated the structural and functional connectivity correlates of fatigue in post-COVID…
-
COVID-19 Symptoms Reduced Among U.S. Healthcare Personnel Receiving Additional Vaccine Doses
On Sept. 25, 2024, U.S. healthcare workers receiving additional vaccine doses during the Omicron period (December 2021 to…
-
Biotechnology | COVID-19 | Diagnostics | NIH | Oncology | Therapeutics | Women's Health
New cancer diagnoses did not rebound as expected following pandemic
On Sept. 24, 2024, researchers at the National Institutes of Health (NIH) reported results of a study that…
-
Study found Pandemic-Era Babies Do Not Have Higher Autism Risk
On Sept. 23, 2024, researchers from Columbia University reported that a study of Children born during the first…
-
epicenter of COVID-19 pandemic Genetically traced to market wildlife and viruses
On Sept. 19, 2024, an international team of researchers announced a study that genetically traced the epicenter of…
-
Study Revealed How COVID-19 Infection Can Cause or Worsen Diabetes
On Sept. 13, 2024, researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the…
-
Novavax 2024-2025 COVID-19 Vaccine Available at Major U.S. Pharmacies
On Sep. 13. 2024, Novavax announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to…
-
Japan’s MHLW Approved CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
On Sept. 13, 2024, CSL Seqirus and sa-mRNA pioneer Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor…
-
Scientists Sequenced Genome of Greenland Shark, world’s longest-living vertebrate
On Sept. 11, 2024, an international team of scientists led by the Leibniz Institute on Aging announced they…
-
Covid-19 pandemic changed scientific publishing
On Sep. 9, 2024, Santo Fortunato, a professor at Luddy School of Informatics, reported that an international research…
-
Novavax Formula COVID-19 Vaccine Authorized and Recommended for Use in the U.S.
On Aug. 30, 2024, Novavax announced the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) had received Emergency Use…
-
Vaccine Misinformation caused U.S. Covid-19 Vaccination rate to Drop
On Aug. 28, 2024, survey data from the Annenberg Public Policy Center (APPC) found that the number of…
-
Pfizer and BioNTech Received U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
On Aug. 22, 2024, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had approved…
-
Biotechnology | CDC | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine
CDC reported COVID-19 at highest level in two years
On Aug. 16, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that COVID-19 infections are…
-
City birds found to be carriers of antimicrobial resistant bacteria
on Aug. 14, 2024, research led by scientists at the Ineos Oxford Institute for antimicrobial research at Oxford…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Vaccine | WHO
WHO/Europe study confirmed lifesaving impact of vaccines against COVID-19 Summer Wave
On Aug. 8, the World Health Organization (WHO) announced results of a study that showed the introduction of…
-
University of Houston Researchers Created New Treatment and Vaccine for Flu and Various Coronaviruses
On Aug. 6, 2024, a team of researchers, led by the University of Houston, announced they had discovered…
-
BioNTech sued by UPenn over COVID-19 vaccine patent royalties
On Aug. 6, 2024, the University of Pennsylvania announced it had sued German biotechnology firm BioNTech n Pennsylvania…
-
CEPI and WHO urge broader research strategy for countries to prepare for the next pandemic
On Aug. 1, 2024, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO) called…
